Claritin
This article was originally published in The Tan Sheet
Executive Summary
Consumer coalition lawsuit against Schering-Plough claims non-sedating antihistamine DTC ads misleadingly imply higher degree of efficacy than has been proven. Prescription Access Litigation Project seeks refunds for consumers' costs of potential switch drug. Schering's legal battles also extend to GMP problems; on Aug. 9, Public Citizen renewed request for criminal investigation into firm's recall of 59 mil. Rx albuterol inhalers
You may also be interested in...
AstraZeneca’s Nexium Marketing Targeted In Consumer Suit
A lawsuit filed in U.S. Superior Court in Los Angeles alleges AstraZeneca employed "unfair and deceptive" practices in promoting its proton pump inhibitor Nexium (esomeprazole)
AstraZeneca’s Nexium Marketing Targeted In Consumer Suit
A lawsuit filed in U.S. Superior Court in Los Angeles alleges AstraZeneca employed "unfair and deceptive" practices in promoting its proton pump inhibitor Nexium (esomeprazole)
AstraZeneca’s Nexium Marketing Targeted In Consumer Suit
A lawsuit filed in U.S. Superior Court in Los Angeles alleges AstraZeneca employed "unfair and deceptive" practices in promoting its proton pump inhibitor Nexium (esomeprazole)